Advances in multiple omics of natural-killer/T cell lymphoma
Open Access
- 4 December 2018
- journal article
- review article
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 11 (1) , 1-7
Abstract
Natural-killer/T cell lymphoma (NKTCL) represents the most common subtype of extranodal lymphoma with aggressive clinical behavior. Prevalent in Asians and South Americans, the pathogenesis of NKTCL remains to be fully elucidated. Using system biology techniques including genomics, transcriptomics, epigenomics, and metabolomics, novel biomarkers and therapeutic targets have been revealed in NKTCL. Whole-exome sequencing studies identify recurrent somatic gene mutations, involving RNA helicases, tumor suppressors, JAK-STAT pathway molecules, and epigenetic modifiers. Another genome-wide association study reports that single nucleotide polymorphisms mapping to the class II MHC region on chromosome 6 contribute to lymphomagenesis. Alterations of oncogenic signaling pathways janus kinase-signal transducer and activator of transcription (JAK-STAT), nuclear factor-κB (NF-κB), mitogen-activated protein kinase (MAPK), WNT, and NOTCH, as well as epigenetic dysregulation of microRNA and long non-coding RNAs, are also frequently observed in NKTCL. As for metabolomic profiling, abnormal amino acids metabolism plays an important role on disease progression of NKTCL. Of note, through targeting multiple omics aberrations, clinical outcome of NKTCL patients has been significantly improved by asparaginase-based regimens, immune checkpoints inhibitors, and histone deacetylation inhibitors. Future investigations will be emphasized on molecular classification of NKTCL using integrated analysis of system biology, so as to optimize targeted therapeutic strategies of NKTCL in the era of precision medicine.Keywords
This publication has 67 references indexed in Scilit:
- Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1Tumor Biology, 2017
- The diagnosis and management of NK/T-cell lymphomasJournal of Hematology & Oncology, 2017
- Omics/systems biology and cancer cachexiaSeminars in Cell & Developmental Biology, 2016
- Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) StudyJournal of Clinical Oncology, 2015
- Global Promoter Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes in Natural Killer Cell LymphomaClinical Cancer Research, 2015
- How I treat NK/T-cell lymphomasBlood, 2013
- Plasma Viral MicroRNA Profiles Reveal Potential Biomarkers for Chronic Active Epstein–Barr Virus InfectionThe Journal of Infectious Diseases, 2013
- A role for Blimp1 in the transcriptional network controlling natural killer cell maturationBlood, 2011
- Activated oncogenic pathways and therapeutic targets in extranodal nasal‐type NK/T cell lymphoma revealed by gene expression profilingThe Journal of Pathology, 2010
- Comparative genomic hybridization study of nasal‐type NK/T‐cell lymphomaCytometry, 2001